Literature DB >> 10864909

Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or Mycobacterium tuberculosis.

J George1, Y Shoenfeld, B Gilburd, A Afek, A Shaish, D Harats.   

Abstract

Atherosclerotic lesions can be induced in rabbits and mice immunized with heat shock protein 65 (HSP65). In the current study, we investigated the role of interleukin (IL)-4 in the HSP65- and Mycobacterium tuberculosis (MT)-induced models that exhibit an inflammatory phenotype. Fatty streak formation in IL-4-knockout (IL-4 KO) mice immunized with HSP65 or MT was significantly reduced when compared with lesions in wild-type C57BL/6 mice. However, when injected with control (HSP-free) adjuvant, no differences were evident in the lesion size between wild-type and the IL-4 KO mice. Next, we studied comparatively the extent of humoral and cellular immune responses to HSP65 in the IL-4 KO and wild-type mice, as those are thought to be influential in murine atherosclerosis. Anti-HSP65 antibody levels were reduced in the HSP65-immunized IL-4 KO mice as compared with their wild-type littermates, whereas no differences were evident between the groups with respect to the primary cellular immune response to HSP65. Other than the absence of IL-4 in the knockout mice, the pattern of secreting cytokines interferon-gamma and IL-10 in concanavalin A-primed splenocytes was similar between the groups. HSP65-primed inguinal lymphocytes from IL-4 KO mice immunized with HSP65 secreted higher levels of interferon-gamma (previously shown to be proatherogenic in vivo) as compared with their wild-type controls. 12-/15-Lipoxygenase expression, known to be regulated by IL-4 and to contribute to murine atherosclerosis, in the lesions was not influenced by the immunization protocol used or by IL-4 disruption. Thus, IL-4 may prove a principal cytokine in the progression of early "inflammatory" atherosclerotic lesions and may serve as a target for immunomodulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10864909     DOI: 10.1161/01.res.86.12.1203

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  19 in total

Review 1.  Antiinflammatory and immunomodulatory properties of statins.

Authors:  Ora Shovman; Yair Levy; Boris Gilburd; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Mycobacterium tuberculosis, autoimmunity, and vitamin D.

Authors:  Yinon Shapira; Nancy Agmon-Levin; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

3.  Heat-shock proteins: inflammatory versus regulatory attributes.

Authors:  Verônica Coelho; Femke Broere; Robert J Binder; Yehuda Shoenfeld; Kamal D Moudgil
Journal:  Cell Stress Chaperones       Date:  2008-02-28       Impact factor: 3.667

Review 4.  The role of heat shock proteins in atherosclerosis.

Authors:  Georg Wick; Bojana Jakic; Maja Buszko; Marius C Wick; Cecilia Grundtman
Journal:  Nat Rev Cardiol       Date:  2014-07-15       Impact factor: 32.419

5.  Atherosclerosis.

Authors:  Y Sherer; Y Shoenfeld
Journal:  Ann Rheum Dis       Date:  2002-02       Impact factor: 19.103

6.  T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm.

Authors:  Uwe Schönbeck; Galina K Sukhova; Norbert Gerdes; Peter Libby
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

7.  The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Piers Davenport; Peter G Tipping
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

Review 8.  Antioxidants, inflammation and cardiovascular disease.

Authors:  Harald Mangge; Kathrin Becker; Dietmar Fuchs; Johanna M Gostner
Journal:  World J Cardiol       Date:  2014-06-26

Review 9.  Macrophage differentiation and function in atherosclerosis: opportunities for therapeutic intervention?

Authors:  Howell J Williams; Edward A Fisher; David R Greaves
Journal:  J Innate Immun       Date:  2012-04-27       Impact factor: 7.349

10.  Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice.

Authors:  Victoria L King; Lisa A Cassis; Alan Daugherty
Journal:  Am J Pathol       Date:  2007-11-30       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.